Biomedical research at Oslo University Hospital
Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
Click here to see hierarchical division and subunit overview
Summary of publications:
Publications (original articles or review articles) published in 2021 from OUS - Department of Endocrinology, Morbid Obesity and Preventive Medicine
8 publications found
No effect of salmon fish protein on 2h-glucose in adults with increased risk of type 2 diabetes: a randomised controlled trial
Br J Nutr, 1-32 (in press)
DOI 10.1017/S0007114521000040, PubMed 33413727
Physical activity and all-cause and cause-specific mortality: assessing the impact of reverse causation and measurement error in two large prospective cohorts
Eur J Epidemiol (in press)
DOI 10.1007/s10654-020-00707-3, PubMed 33428024
The first modified Delphi consensus statement on sleeve gastrectomy
Surg Endosc (in press)
DOI 10.1007/s00464-020-08216-w, PubMed 33433676
Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension
Blood Press, 1-8 (in press)
DOI 10.1080/08037051.2020.1855968, PubMed 33403886
Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk
Blood Press
DOI 10.1080/08037051.2020.1856642, PubMed 33403890
Establishing Serum Reference Ranges for Antihypertensive Drugs
Ther Drug Monit, 43 (1), 116-125
DOI 10.1097/FTD.0000000000000806, PubMed 32881780
L.C. Stene og medarbeidere svarer
Tidsskr Nor Laegeforen, 141 (1)
DOI 10.4045/tidsskr.20.1028, PubMed 33433091
Changes in sympathetic nervous system activity after renal denervation: results from the randomised Oslo RDN study
Blood Press
DOI 10.1080/08037051.2020.1868286, PubMed 33399016